M&A Deal Summary |
|
|---|---|
| Date | 2022-06-13 |
| Target | Biomedical Diagnostics |
| Sector | Healthcare Services |
| Buyer(s) | Eurobio Scientific |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1997 |
| Sector | Healthcare Services |
| Employees | 326 |
| Revenue | 155M EUR (2024) |
Eurobio Scientific is involved in the manufacturing and commercialization of diagnostic tests in the fields of transplantation, immunology, and infectious diseases, and sells instruments and products for research laboratories, including biotechnology and pharmaceutical companies. Through many partnerships and a strong presence in hospitals, the group has established its own distribution network and a portfolio of proprietary products in the molecular biology field. Eurobio was founded in 1997 and is based in Les Ulis, France.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 4 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 3 |
| Country: Belgium M&A | 1 of 1 |
| Year: 2022 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-10-03 |
GenDx
Utrecht, Netherlands GenDx is a Dutch company specializing in Molecular Diagnostics, focused on the development, production, and sales of innovative assays and analysis software for transplantation and companion diagnostics. GenDx specializes in HLA sequencing-based typing strategies and offers reagents and software for both Sanger and NGS approaches. GenDx was founded in 2005 and is based in Utrecht, Netherlands. |
Buy | €135M |
